OBJECTIVE: This study sought to estimate the incidence and incidence rate of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) at a high-volume single institution, which enables vigorous long-term follow-up and implant tracking for more accurate estimates. SUMMARY BACKGROUND DATA: The reported incidence of BIA-ALCL is highly variable, ranging from 1 in 355 to 1 in 30,000 patients, demonstrating a need for more accurate estimates. METHODS: All patients who underwent implant-based breast reconstruction from 1991 to 2017 were retrospectively identified. The incidence and incidence rate of BIA-ALCL were estimated per patient and per implant. A time-to-event analysis was performed using the Kaplan-Meier estimator and life table. RESULTS: During the 26-year study period, 9373 patients underwent reconstruction with 16,065 implants, of which 9589 (59.7%) were textured. Eleven patients were diagnosed with BIA-ALCL, all of whom had a history of textured implants. The overall incidence of BIA-ALCL was 1.79 per 1000 patients (1 in 559) with textured implants and 1.15 per 1000 textured implants (1 in 871), with a median time to diagnosis of 10.3 years (range, 6.4-15.5 yrs). Time-to-event analysis demonstrated a BIA-ALCL cumulative incidence of 0 at up to 6 years, increasing to 4.4 per 1000 patients at 10 to 12 years and 9.4 per 1000 patients at 14 to 16 years, although a sensitivity analysis showed loss to follow-up may have skewed these estimates. CONCLUSIONS: BIA-ALCL incidence and incidence rates may be higher than previous epidemiological estimates, with incidence increasing over time, particularly in patients exposed to textured implants for longer than 10 years.
OBJECTIVE: This study sought to estimate the incidence and incidence rate of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) at a high-volume single institution, which enables vigorous long-term follow-up and implant tracking for more accurate estimates. SUMMARY BACKGROUND DATA: The reported incidence of BIA-ALCL is highly variable, ranging from 1 in 355 to 1 in 30,000 patients, demonstrating a need for more accurate estimates. METHODS: All patients who underwent implant-based breast reconstruction from 1991 to 2017 were retrospectively identified. The incidence and incidence rate of BIA-ALCL were estimated per patient and per implant. A time-to-event analysis was performed using the Kaplan-Meier estimator and life table. RESULTS: During the 26-year study period, 9373 patients underwent reconstruction with 16,065 implants, of which 9589 (59.7%) were textured. Eleven patients were diagnosed with BIA-ALCL, all of whom had a history of textured implants. The overall incidence of BIA-ALCL was 1.79 per 1000 patients (1 in 559) with textured implants and 1.15 per 1000 textured implants (1 in 871), with a median time to diagnosis of 10.3 years (range, 6.4-15.5 yrs). Time-to-event analysis demonstrated a BIA-ALCL cumulative incidence of 0 at up to 6 years, increasing to 4.4 per 1000 patients at 10 to 12 years and 9.4 per 1000 patients at 14 to 16 years, although a sensitivity analysis showed loss to follow-up may have skewed these estimates. CONCLUSIONS: BIA-ALCL incidence and incidence rates may be higher than previous epidemiological estimates, with incidence increasing over time, particularly in patients exposed to textured implants for longer than 10 years.
Authors: M Bradley Calobrace; Michael R Schwartz; Kamakshi R Zeidler; Troy A Pittman; Robert Cohen; W Grant Stevens Journal: Aesthet Surg J Date: 2017-12-13 Impact factor: 4.283
Authors: Garry S Brody; Dennis Deapen; Clive R Taylor; Lauren Pinter-Brown; Sarah Rose House-Lightner; James S Andersen; Grant Carlson; Melissa G Lechner; Alan L Epstein Journal: Plast Reconstr Surg Date: 2015-03 Impact factor: 4.730
Authors: Marshall E Kadin; Anand Deva; Haiying Xu; John Morgan; Pranay Khare; Roderick A F MacLeod; Bruce W Van Natta; William P Adams; Garry S Brody; Alan L Epstein Journal: Aesthet Surg J Date: 2016-03-15 Impact factor: 4.283
Authors: Melissa G Lechner; Carolina Megiel; Connor H Church; Trevor E Angell; Sarah M Russell; Rikki B Sevell; Julie K Jang; Garry S Brody; Alan L Epstein Journal: Clin Cancer Res Date: 2012-07-12 Impact factor: 12.531
Authors: Ashley N Leberfinger; Brittany J Behar; Nicole C Williams; Kevin L Rakszawski; John D Potochny; Donald R Mackay; Dino J Ravnic Journal: JAMA Surg Date: 2017-12-01 Impact factor: 14.766
Authors: Stefan Dabic; Colleen M McCarthy; Evan Matros; Joseph J Disa; Babak J Mehrara; Jonas A Nelson Journal: Plast Reconstr Surg Date: 2021-09-01 Impact factor: 5.169
Authors: Evan B Lynch; Ryan C DeCoster; Krishna S Vyas; Brian D Rinker; Mei Yang; Henry C Vasconez; Mark W Clemens Journal: Ann Breast Surg Date: 2021-09-30
Authors: Evan Matros; Meghana G Shamsunder; Robyn N Rubenstein; Thais O Polanco; Colleen M McCarthy; Jonas A Nelson; Karol Gutowski; The Tops Steering Committee Journal: Plast Reconstr Surg Glob Open Date: 2021-03-18
Authors: Mohamed Amir Mrad; Sawsan A Alharthi; Loujain A Alyousef; Abdullah E Kattan; Qutaiba N M Shah Mardan Journal: Plast Reconstr Surg Glob Open Date: 2021-11-22